[Use of Padrin compound in urological practice].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy*; D011183:Postoperative Complications / Q000188:drug therapy; D011720:Pyrazoles / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use*; D013451:Sulfonic Acids / Q000627:therapeutic use; D014570:Urologic Diseases / Q000150:complications*
D000700:Analgesics; D000927:Anticonvulsants; D011720:Pyrazoles; D011759:Pyrrolidines; D013451:Sulfonic Acids